Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-11

FDA Approved: RALOXIFENE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for raloxifene hydrochloride from Amneal Pharmaceuticals LLC, authorizing a regulatory change under the supplemental app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

SUPPL AP for RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)